Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1708 (LINC01708) is a non-coding RNA gene that is transcribed but not translated into protein. It belongs to the lincRNA family, which are defined as transcripts longer than 200 nucleotides that do not overlap protein-coding genes and are involved in diverse regulatory functions in the cell. LincRNAs, including LINC01708, have been implicated in chromatin remodeling, transcriptional and epigenetic regulation, and RNA stabilization, with possible context-dependent functions such as enhancer association. While several lincRNAs play crucial roles in processes like cancer and gene expression regulation, LINC01708 itself does not currently have established status as a therapeutic target or a defined function, and there are no known specific drugs or clinical biomarkers associated with it at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1708 (LINC01708).